Background: To investigate the clinical value of serum concentration of carcinoembryonic
antigen (CEA), carbohydrate antigen 24-2 (CA24-2), and carbohydrate antigen 19-9 (CA19 …

Objective: The purpose of this study was to evaluate the diagnostic efficiency of colorectal
carcinoma (CRC) with the tumor markers Carcinoembryonic Antigen (CEA) and …

Background: High concentrations of carcinoembryonic antigen (CEA) and carbohydrate
antigen 19-9 (CA19-9) were found in the serum of patients with colon cancer. We performed …

Carcinoembryonic antigen (CEA), originally described by Gold and Freedman [1] in 1965, is
now an acknowledged member of immunoglobulin superfamily [2], with a role as an …

Aims: This study evaluated the prognostic value of the preoperative CEA and CA 19-9 levels
on the survival time and TNM staging in patients with colorectal cancer. Methodology: We …

Carcinoembryonic Antigen (CEA) and CA 19-9 are tumor markers expressed by colorectal
cancers (CR), particularly in advanced cases. The aim of this study was to evaluate the …

Objective: The purpose of this study was to evaluate and compare serum tumor markers,
carcinoembryonic antigen (CEA), CA 19-9, CA 242, CA 72-4 and hCGβ, and their value in …

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early
stages with enhanced screening methods is vital as metastases and recurrences increase …

Tumor markers such as carcinoembryonic antigen (CEA) and CA19‐9 were analyzed as
response indicators and prognostic factors in advanced colorectal carcinoma. Eighty‐five …

Purpose Limited data are available regarding the association between circulating serum
carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA 19-9) concentrations …